复发性静脉血栓形成的流行病学。
Epidemiology of recurrent venous thrombosis.
机构信息
Divisão de Hemostasia, Departamento de Hematologia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.
出版信息
Braz J Med Biol Res. 2012 Jan;45(1):1-7. doi: 10.1590/s0100-879x2011007500166. Epub 2011 Dec 23.
Abstract
Venous thrombosis, including deep vein thrombosis and pulmonary embolism, is a common disease that frequently recurs. Recurrence can be prevented by anticoagulants, but this comes at the risk of bleeding. Therefore, assessment of the risk of recurrence is important to balance the risks and benefits of anticoagulant treatment. This review briefly outlines what is currently known about the epidemiology of recurrent venous thrombosis, and focuses in more detail on potential new risk factors for venous recurrence. The general implications of these findings in patient management are discussed.
摘要
静脉血栓形成，包括深静脉血栓形成和肺栓塞，是一种常见的疾病，经常复发。抗凝剂可以预防复发，但这存在出血的风险。因此，评估复发风险对于平衡抗凝治疗的风险和益处非常重要。本综述简要概述了目前已知的复发性静脉血栓形成的流行病学情况，并更详细地介绍了静脉血栓复发的潜在新危险因素。讨论了这些发现对患者管理的一般影响。
相似文献
1
Epidemiology of recurrent venous thrombosis.复发性静脉血栓形成的流行病学。
Braz J Med Biol Res. 2012 Jan;45(1):1-7. doi: 10.1590/s0100-879x2011007500166. Epub 2011 Dec 23.
2
Risk assessment for recurrent venous thrombosis.复发性静脉血栓形成的风险评估。
Lancet. 2010 Dec 11;376(9757):2032-9. doi: 10.1016/S0140-6736(10)60962-2. Epub 2010 Dec 3.
3
Treatment of DVT: how long is enough and how do you predict recurrence.深静脉血栓形成的治疗：治疗时长多久足够以及如何预测复发
J Thromb Thrombolysis. 2008 Feb;25(1):37-44. doi: 10.1007/s11239-007-0103-z. Epub 2007 Oct 1.
4
Duration of anticoagulation treatment in patients with venous thromboembolism.静脉血栓栓塞症患者的抗凝治疗持续时间。
J Am Osteopath Assoc. 2010 Nov;110(11):638-44.
5
6
Deep vein thrombosis and pulmonary embolism.深静脉血栓形成和肺栓塞。
Lancet. 2016 Dec 17;388(10063):3060-3073. doi: 10.1016/S0140-6736(16)30514-1. Epub 2016 Jun 30.
7
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.不明原因静脉血栓栓塞症患者复发性血栓栓塞性疾病的风险：新情况与新机遇
Eur J Intern Med. 2014 Jan;25(1):25-30. doi: 10.1016/j.ejim.2013.09.005. Epub 2013 Oct 9.
8
Posttreatment ultrasound-detected residual venous thrombosis: a risk factor for recurrent venous thromboembolism and mortality.治疗后超声检测到的残余静脉血栓形成：复发性静脉血栓栓塞和死亡的危险因素。
Curr Opin Pulm Med. 2007 Sep;13(5):403-8. doi: 10.1097/MCP.0b013e32821642fb.
9
[Recurrence risk in venous thromboembolic disease after anticoagulation discontinuation].[抗凝治疗中断后静脉血栓栓塞性疾病的复发风险]
Med Clin (Barc). 2013 Apr 15;140(7):310-3. doi: 10.1016/j.medcli.2012.06.023. Epub 2012 Sep 18.
10
Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study.评估英国二级护理中开具利伐沙班治疗和预防深静脉血栓形成和肺栓塞的患者出血发生率：一项观察性队列研究。
BMJ Open. 2020 Nov 3;10(11):e038102. doi: 10.1136/bmjopen-2020-038102.
引用本文的文献
1
Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history: A prospective population-based study.纤维蛋白原基因型及其对静脉血栓栓塞复发和家族史的影响：一项基于人群的前瞻性研究。
Br J Haematol. 2025 Feb;206(2):657-665. doi: 10.1111/bjh.19999. Epub 2025 Jan 19.
2
Joint Guideline on Venous Thromboembolism - 2022.《静脉血栓栓塞症联合指南 - 2022》
Arq Bras Cardiol. 2022 Apr;118(4):797-857. doi: 10.36660/abc.20220213.
3
Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study.韩国癌症合并静脉血栓栓塞症患者的治疗模式和临床结局：一项回顾性队列研究。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620979575. doi: 10.1177/1076029620979575.
4
Recurrent Deep Vein Thrombosis After the First Venous Thromboembolism Event: A Single-Institution Experience.首次静脉血栓栓塞事件后复发性深静脉血栓形成：单机构经验
Med Sci Monit. 2017 May 20;23:2391-2399. doi: 10.12659/msm.901924.
5
Von Willebrand factor is reversibly decreased during torpor in 13-lined ground squirrels.在13条纹地松鼠蛰伏期间，血管性血友病因子会可逆性降低。
J Comp Physiol B. 2016 Jan;186(1):131-9. doi: 10.1007/s00360-015-0941-5.
6
Clinical update on pulmonary embolism.肺栓塞的临床更新。
Arch Med Sci. 2014 Jun 29;10(3):557-65. doi: 10.5114/aoms.2013.34325. Epub 2013 May 7.
本文引用的文献
1
Past provoking venous thrombosis risk situations on the risk of a recurrent thrombotic event: a cohort study.既往诱发静脉血栓形成的风险情况对复发性血栓事件的风险：一项队列研究。
Thromb Res. 2011 Sep;128(3):227-32. doi: 10.1016/j.thromres.2011.04.015. Epub 2011 May 19.
2
Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review.近端深静脉血栓形成患者残留静脉血栓形成作为复发性静脉血栓栓塞的预测因素：系统评价。
Br J Haematol. 2011 Apr;153(2):168-78. doi: 10.1111/j.1365-2141.2011.08578.x. Epub 2011 Mar 6.
3
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.男女静脉血栓栓塞后复发的风险：患者水平荟萃分析。
BMJ. 2011 Feb 24;342:d813. doi: 10.1136/bmj.d813.
4
Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.延长抗凝治疗用于无诱因静脉血栓栓塞：大多数患者应接受治疗。
J Thromb Thrombolysis. 2011 Apr;31(3):295-300. doi: 10.1007/s11239-011-0573-x.
5
Risk of recurrent venous thromboembolism according to malignancy characteristics in patients with cancer-associated thrombosis: a systematic review of observational and intervention studies.癌症相关血栓形成患者中，根据恶性肿瘤特征评估复发性静脉血栓栓塞的风险：观察性研究和干预性研究的系统评价
Blood Coagul Fibrinolysis. 2011 Mar;22(2):86-91. doi: 10.1097/MBC.0b013e328341f030.
6
Risk assessment for recurrent venous thrombosis.复发性静脉血栓形成的风险评估。
Lancet. 2010 Dec 11;376(9757):2032-9. doi: 10.1016/S0140-6736(10)60962-2. Epub 2010 Dec 3.
7
Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event.性别差异与复发性静脉血栓形成风险及二次事件风险特征。
J Thromb Haemost. 2010 Oct;8(10):2159-68. doi: 10.1111/j.1538-7836.2010.03994.x.
8
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis.静脉血栓形成的临床表现和范围是否可预测复发的可能性和类型？一项基于患者水平的荟萃分析。
J Thromb Haemost. 2010 Nov;8(11):2436-42. doi: 10.1111/j.1538-7836.2010.04022.x.
9
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management.癌症患者的静脉血栓栓塞：ESMO临床实践管理指南
Ann Oncol. 2010 May;21 Suppl 5:v274-6. doi: 10.1093/annonc/mdq199.
10
Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension.性别、年龄和正常抗凝后 D-二聚体是 Prolong 研究扩展后特发性静脉血栓栓塞复发的危险因素。
J Thromb Haemost. 2010 Sep;8(9):1933-42. doi: 10.1111/j.1538-7836.2010.03955.x.
Zotero 插件